U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H39NO5S
Molecular Weight 489.667
Optical Activity ( - )
Defined Stereocenters 5 / 5
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of KOS-1584

SMILES

C[C@H]1\C=C\CC(C)=CC[C@H](OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@H]1O)C(\C)=C\C2=CSC(C)=N2

InChI

InChIKey=XAYAKDZVINDZGB-BMVMHAJPSA-N
InChI=1S/C27H39NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h8,10-11,13,15,17,19,22-23,25,29,31H,9,12,14H2,1-7H3/b10-8+,16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1

HIDE SMILES / InChI

Molecular Formula C27H39NO5S
Molecular Weight 489.667
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 1
Optical Activity UNSPECIFIED

Description

KOS-1584 is a second-generation epothilone D analog designed to have less toxicity, more potency, and higher solubility compared with epothilone D. It has a broad spectrum of potent antiproliferative activity on tumor cells. Currently, KOS-1584 is under clinical evaluation.

Originator

Approval Year

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
The recommended phase II dose is 36 mg/m2.
Route of Administration: Intravenous
Substance Class Chemical
Record UNII
82481G197K
Record Status Validated (UNII)
Record Version